
BIONTECH SE
BNTX
![]() |
|
107.265USD | -2.67% |
Turn to zoom
Prev. | 110.2100 |
Open | 109.8600 |
High | 109.8600 |
Low | 106.2300 |
Volume | 316 120 |
Latest news
Chart BIONTECH SE
Technical analysis trends
Short Term | Mid-Term | Long Term | |
Trend | Bullish | Neutral | Bullish |
Resistance | 120 | 130 | 127 |
Spread/Res. | -11% | -18% | -16% |
Spread/Supp. | -2,4% | 84% | 46% |
Support | 109 | 57,8 | 73,0 |
Financials
|
|
Company
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including...
>> Read more
>> Read more
Sector : |
Bio Therapeutic Drugs
|
Calendar : |
2021-03-02 Presentation
|
Trading Rating : |
Investor Rating : |
Income Statement Evolution
Consensus
Mean consensus | OUTPERFORM |
Number of Analysts | 11 |
Average target price | 94,33 € |
Last Close Price | 91,48 € |
Spread / Highest target | 22,7% |
Spread / Average Target | 3,12% |
Spread / Lowest Target | -31,6% |